Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angiotensin I | 59 | 2021 | 241 | 8.950 |
Why?
|
Peptide Fragments | 62 | 2021 | 399 | 8.880 |
Why?
|
Peptidyl-Dipeptidase A | 46 | 2021 | 132 | 8.170 |
Why?
|
Renin-Angiotensin System | 48 | 2021 | 179 | 8.110 |
Why?
|
Kidney | 36 | 2019 | 518 | 6.430 |
Why?
|
Angiotensin II | 48 | 2021 | 244 | 5.470 |
Why?
|
Hypertension | 42 | 2019 | 960 | 4.940 |
Why?
|
Renin | 33 | 2019 | 109 | 4.400 |
Why?
|
Receptors, G-Protein-Coupled | 16 | 2019 | 85 | 3.820 |
Why?
|
Blood Pressure | 55 | 2019 | 845 | 3.330 |
Why?
|
Animals | 118 | 2021 | 7542 | 2.890 |
Why?
|
Kidney Tubules, Proximal | 9 | 2017 | 40 | 2.540 |
Why?
|
Angiotensins | 16 | 2018 | 42 | 2.500 |
Why?
|
Prenatal Exposure Delayed Effects | 18 | 2019 | 92 | 2.390 |
Why?
|
Betamethasone | 17 | 2019 | 53 | 2.360 |
Why?
|
Rats | 60 | 2020 | 1596 | 2.230 |
Why?
|
Angiotensinogen | 16 | 2016 | 59 | 2.070 |
Why?
|
Nitric Oxide | 11 | 2018 | 111 | 1.930 |
Why?
|
Receptor, Angiotensin, Type 1 | 14 | 2017 | 65 | 1.890 |
Why?
|
Sheep | 26 | 2018 | 233 | 1.810 |
Why?
|
Rats, Inbred Lew | 26 | 2020 | 118 | 1.760 |
Why?
|
Estrogens | 7 | 2014 | 180 | 1.700 |
Why?
|
Sodium Chloride, Dietary | 8 | 2016 | 28 | 1.650 |
Why?
|
Glucocorticoids | 14 | 2019 | 146 | 1.640 |
Why?
|
Estradiol | 7 | 2013 | 136 | 1.590 |
Why?
|
Cell Nucleus | 5 | 2014 | 108 | 1.540 |
Why?
|
Mitochondria | 5 | 2019 | 187 | 1.520 |
Why?
|
Receptors, Angiotensin | 9 | 2011 | 61 | 1.490 |
Why?
|
Ovariectomy | 11 | 2013 | 166 | 1.480 |
Why?
|
Baroreflex | 13 | 2019 | 84 | 1.460 |
Why?
|
Proto-Oncogene Proteins | 7 | 2019 | 85 | 1.300 |
Why?
|
Cyclopentanes | 7 | 2016 | 16 | 1.260 |
Why?
|
Quinolines | 7 | 2016 | 21 | 1.260 |
Why?
|
Oxidative Stress | 9 | 2019 | 231 | 1.230 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 15 | 2012 | 135 | 1.180 |
Why?
|
Vasodilation | 7 | 2017 | 94 | 1.160 |
Why?
|
Kidney Cortex | 6 | 2015 | 25 | 1.150 |
Why?
|
Signal Transduction | 10 | 2019 | 682 | 1.140 |
Why?
|
Myocardium | 13 | 2014 | 186 | 1.060 |
Why?
|
Female | 63 | 2021 | 20015 | 1.040 |
Why?
|
Peptide Hydrolases | 3 | 2015 | 17 | 1.000 |
Why?
|
Reactive Oxygen Species | 8 | 2019 | 157 | 0.970 |
Why?
|
Male | 68 | 2020 | 19217 | 0.930 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 13 | 2019 | 65 | 0.930 |
Why?
|
Pregnancy | 28 | 2019 | 997 | 0.910 |
Why?
|
Medulla Oblongata | 7 | 2019 | 51 | 0.890 |
Why?
|
Epithelial Cells | 5 | 2016 | 141 | 0.880 |
Why?
|
Nitric Oxide Synthase Type III | 4 | 2018 | 36 | 0.880 |
Why?
|
Carboxypeptidases | 8 | 2005 | 21 | 0.870 |
Why?
|
Humans | 45 | 2021 | 32114 | 0.820 |
Why?
|
Mesenteric Arteries | 5 | 2013 | 20 | 0.820 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 153 | 0.810 |
Why?
|
Gene Expression Regulation | 10 | 2012 | 495 | 0.800 |
Why?
|
Radioimmunoassay | 3 | 2021 | 25 | 0.780 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2017 | 94 | 0.770 |
Why?
|
Imidazoles | 11 | 2017 | 91 | 0.770 |
Why?
|
Fetal Development | 4 | 2018 | 26 | 0.760 |
Why?
|
Fetus | 2 | 2019 | 86 | 0.710 |
Why?
|
Aging | 8 | 2013 | 946 | 0.700 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2017 | 6 | 0.700 |
Why?
|
Proteinuria | 8 | 2014 | 59 | 0.660 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2013 | 63 | 0.640 |
Why?
|
Tetrazoles | 10 | 2019 | 61 | 0.630 |
Why?
|
Coronavirus Infections | 1 | 2020 | 99 | 0.620 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 103 | 0.620 |
Why?
|
Losartan | 10 | 2017 | 64 | 0.610 |
Why?
|
Blotting, Western | 9 | 2017 | 289 | 0.610 |
Why?
|
Diastole | 5 | 2014 | 96 | 0.590 |
Why?
|
Mice | 21 | 2017 | 2484 | 0.590 |
Why?
|
Renal Artery | 2 | 2017 | 47 | 0.590 |
Why?
|
Immunohistochemistry | 13 | 2013 | 538 | 0.580 |
Why?
|
Receptors, Bradykinin | 1 | 2017 | 2 | 0.580 |
Why?
|
Molecular Probe Techniques | 1 | 2017 | 4 | 0.570 |
Why?
|
Premature Birth | 4 | 2019 | 66 | 0.560 |
Why?
|
Amiloride | 1 | 2016 | 5 | 0.560 |
Why?
|
Sodium | 8 | 2017 | 39 | 0.550 |
Why?
|
Disease Models, Animal | 20 | 2019 | 1022 | 0.550 |
Why?
|
Cardiovascular System | 2 | 2019 | 43 | 0.550 |
Why?
|
Conjunctival Diseases | 1 | 2016 | 4 | 0.540 |
Why?
|
Lisinopril | 6 | 2012 | 26 | 0.540 |
Why?
|
Eye Injuries | 1 | 2016 | 16 | 0.530 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2014 | 170 | 0.520 |
Why?
|
Rats, Transgenic | 14 | 2019 | 47 | 0.520 |
Why?
|
Ornithine | 2 | 2012 | 4 | 0.510 |
Why?
|
Neprilysin | 7 | 2013 | 31 | 0.510 |
Why?
|
Heart | 7 | 2019 | 177 | 0.500 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2012 | 54 | 0.490 |
Why?
|
Antihypertensive Agents | 8 | 2019 | 352 | 0.490 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 1128 | 0.490 |
Why?
|
Nitric Oxide Synthase | 4 | 2014 | 35 | 0.480 |
Why?
|
Nitric Oxide Synthase Type I | 2 | 2012 | 17 | 0.480 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 35 | 0.480 |
Why?
|
Sex Factors | 11 | 2019 | 667 | 0.480 |
Why?
|
RNA, Messenger | 14 | 2015 | 508 | 0.470 |
Why?
|
Diabetic Nephropathies | 2 | 2013 | 224 | 0.450 |
Why?
|
Choroid Plexus | 1 | 2013 | 3 | 0.450 |
Why?
|
Cyclic AMP | 1 | 2013 | 46 | 0.450 |
Why?
|
Brain | 8 | 2019 | 951 | 0.430 |
Why?
|
Receptors, Estrogen | 2 | 2014 | 113 | 0.410 |
Why?
|
Kidney Glomerulus | 1 | 2012 | 30 | 0.400 |
Why?
|
Hypertension, Renal | 3 | 2007 | 29 | 0.400 |
Why?
|
Sex Characteristics | 4 | 2015 | 173 | 0.390 |
Why?
|
Cell Line | 5 | 2016 | 435 | 0.390 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2011 | 80 | 0.390 |
Why?
|
Receptor, Angiotensin, Type 2 | 2 | 2009 | 22 | 0.390 |
Why?
|
Pyridines | 7 | 2017 | 76 | 0.380 |
Why?
|
Kidney Diseases | 3 | 2012 | 249 | 0.380 |
Why?
|
NG-Nitroarginine Methyl Ester | 4 | 2017 | 18 | 0.380 |
Why?
|
Vagus Nerve | 3 | 2019 | 29 | 0.370 |
Why?
|
Heart Rate | 13 | 2019 | 335 | 0.370 |
Why?
|
Scleroderma, Systemic | 1 | 2010 | 7 | 0.360 |
Why?
|
Down-Regulation | 4 | 2015 | 142 | 0.350 |
Why?
|
Autoantibodies | 1 | 2010 | 49 | 0.350 |
Why?
|
Benzimidazoles | 6 | 2019 | 28 | 0.350 |
Why?
|
Leucine | 5 | 2010 | 20 | 0.350 |
Why?
|
Dinoprost | 2 | 2014 | 10 | 0.350 |
Why?
|
Enzyme Inhibitors | 4 | 2011 | 166 | 0.320 |
Why?
|
Protease Inhibitors | 3 | 2014 | 14 | 0.320 |
Why?
|
Time Factors | 11 | 2016 | 2151 | 0.320 |
Why?
|
Pre-Eclampsia | 3 | 2015 | 66 | 0.310 |
Why?
|
Carboxypeptidases A | 1 | 2008 | 1 | 0.310 |
Why?
|
Chromatography, Agarose | 2 | 2021 | 5 | 0.310 |
Why?
|
Bradykinin | 3 | 2017 | 12 | 0.290 |
Why?
|
Acute Radiation Syndrome | 2 | 2016 | 3 | 0.280 |
Why?
|
Sympathetic Nervous System | 3 | 2019 | 31 | 0.280 |
Why?
|
Solitary Nucleus | 4 | 2011 | 34 | 0.280 |
Why?
|
Oligopeptides | 3 | 2016 | 45 | 0.280 |
Why?
|
Animals, Congenic | 6 | 2016 | 14 | 0.270 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2005 | 5 | 0.260 |
Why?
|
Substrate Specificity | 3 | 2014 | 87 | 0.250 |
Why?
|
Hemodynamics | 3 | 2019 | 155 | 0.250 |
Why?
|
Fibrosis | 4 | 2010 | 120 | 0.250 |
Why?
|
Cardiomegaly | 4 | 2010 | 30 | 0.250 |
Why?
|
Sheep, Domestic | 4 | 2019 | 18 | 0.250 |
Why?
|
Aldosterone | 4 | 2014 | 26 | 0.240 |
Why?
|
Placenta | 2 | 2019 | 74 | 0.240 |
Why?
|
Age Factors | 6 | 2019 | 1189 | 0.230 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 105 | 0.230 |
Why?
|
Infant, Premature | 3 | 2018 | 69 | 0.230 |
Why?
|
Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
Up-Regulation | 4 | 2013 | 189 | 0.220 |
Why?
|
Aorta | 2 | 2016 | 126 | 0.220 |
Why?
|
Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2016 | 633 | 0.210 |
Why?
|
Islets of Langerhans | 1 | 2003 | 76 | 0.210 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
Pancreas | 1 | 2003 | 103 | 0.210 |
Why?
|
Transients and Migrants | 1 | 2016 | 297 | 0.210 |
Why?
|
Mice, Knockout | 6 | 2017 | 443 | 0.210 |
Why?
|
Virus Internalization | 2 | 2020 | 7 | 0.200 |
Why?
|
Rats, Sprague-Dawley | 12 | 2012 | 743 | 0.200 |
Why?
|
Enzyme Activation | 4 | 2019 | 135 | 0.200 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 582 | 0.200 |
Why?
|
Phenylephrine | 3 | 2017 | 28 | 0.200 |
Why?
|
Hypertrophy | 2 | 2014 | 27 | 0.200 |
Why?
|
Ventricular Function, Left | 3 | 2014 | 245 | 0.200 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 156 | 0.190 |
Why?
|
Gestational Age | 4 | 2019 | 121 | 0.190 |
Why?
|
Reference Standards | 1 | 2021 | 32 | 0.190 |
Why?
|
Specimen Handling | 1 | 2021 | 33 | 0.190 |
Why?
|
Models, Animal | 3 | 2011 | 169 | 0.180 |
Why?
|
Endothelial Cells | 2 | 2012 | 189 | 0.180 |
Why?
|
Rats, Inbred SHR | 9 | 2011 | 31 | 0.180 |
Why?
|
Biological Transport | 2 | 2017 | 69 | 0.180 |
Why?
|
Heart Failure, Diastolic | 2 | 2011 | 15 | 0.170 |
Why?
|
Nephrectomy | 2 | 2012 | 123 | 0.170 |
Why?
|
Nitrates | 2 | 2012 | 27 | 0.170 |
Why?
|
Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
Whole-Body Irradiation | 2 | 2016 | 53 | 0.170 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 14 | 0.170 |
Why?
|
Protein Transport | 2 | 2016 | 74 | 0.160 |
Why?
|
Organophosphorus Compounds | 1 | 2019 | 33 | 0.160 |
Why?
|
Hydrolysis | 2 | 2016 | 35 | 0.160 |
Why?
|
C-Reactive Protein | 2 | 2012 | 238 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2015 | 69 | 0.160 |
Why?
|
Hydrogen Sulfide | 1 | 2018 | 3 | 0.160 |
Why?
|
PPAR delta | 1 | 2018 | 3 | 0.160 |
Why?
|
Glomerular Filtration Rate | 4 | 2018 | 308 | 0.160 |
Why?
|
Pregnancy, Animal | 2 | 2011 | 19 | 0.150 |
Why?
|
Piperidines | 1 | 2019 | 118 | 0.150 |
Why?
|
Immunoblotting | 2 | 2009 | 51 | 0.150 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2017 | 1 | 0.150 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 13 | 0.150 |
Why?
|
Kinetics | 3 | 2014 | 209 | 0.150 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 39 | 0.150 |
Why?
|
Myocytes, Cardiac | 4 | 2011 | 86 | 0.150 |
Why?
|
Chymases | 3 | 2013 | 8 | 0.150 |
Why?
|
Trachea | 1 | 2017 | 52 | 0.140 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 109 | 0.140 |
Why?
|
Guanylate Cyclase | 1 | 2017 | 8 | 0.140 |
Why?
|
Risk Factors | 4 | 2019 | 3880 | 0.140 |
Why?
|
Pneumonia | 1 | 2017 | 68 | 0.140 |
Why?
|
Cell-Free System | 1 | 2017 | 15 | 0.140 |
Why?
|
Analysis of Variance | 4 | 2011 | 464 | 0.140 |
Why?
|
Sodium, Dietary | 3 | 2015 | 23 | 0.140 |
Why?
|
Mitochondrial Membranes | 1 | 2016 | 21 | 0.140 |
Why?
|
Phosphorylation | 2 | 2014 | 229 | 0.140 |
Why?
|
Gamma Rays | 1 | 2016 | 25 | 0.140 |
Why?
|
Radiation Injuries, Experimental | 1 | 2016 | 36 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2016 | 62 | 0.140 |
Why?
|
Trauma Severity Indices | 1 | 2016 | 49 | 0.140 |
Why?
|
Kidney Medulla | 2 | 2006 | 29 | 0.140 |
Why?
|
Overweight | 1 | 2018 | 280 | 0.140 |
Why?
|
Florida | 1 | 2016 | 37 | 0.130 |
Why?
|
Chorionic Villi | 1 | 2015 | 7 | 0.130 |
Why?
|
Dual Specificity Phosphatase 1 | 2 | 2012 | 29 | 0.130 |
Why?
|
Body Weight | 4 | 2012 | 310 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 122 | 0.130 |
Why?
|
Organ Size | 3 | 2012 | 218 | 0.130 |
Why?
|
Insulysin | 1 | 2015 | 6 | 0.120 |
Why?
|
Rats, Inbred WKY | 6 | 2011 | 18 | 0.120 |
Why?
|
Infant, Newborn | 4 | 2018 | 672 | 0.120 |
Why?
|
Albumins | 1 | 2014 | 45 | 0.120 |
Why?
|
Animals, Genetically Modified | 4 | 2008 | 66 | 0.120 |
Why?
|
Mercury Compounds | 1 | 2014 | 2 | 0.120 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 2014 | 3 | 0.120 |
Why?
|
Neurotensin | 1 | 2014 | 4 | 0.120 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 36 | 0.120 |
Why?
|
Heart Diseases | 1 | 2015 | 116 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 64 | 0.120 |
Why?
|
Cattle | 1 | 2014 | 103 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 66 | 0.120 |
Why?
|
Vascular Resistance | 2 | 2011 | 31 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 2 | 2014 | 199 | 0.120 |
Why?
|
Phenanthrolines | 1 | 2013 | 3 | 0.120 |
Why?
|
p-Chloromercuribenzoic Acid | 1 | 2013 | 3 | 0.120 |
Why?
|
Phenylmercuric Acetate | 1 | 2013 | 4 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 70 | 0.120 |
Why?
|
Edetic Acid | 1 | 2013 | 8 | 0.120 |
Why?
|
Random Allocation | 5 | 2013 | 228 | 0.110 |
Why?
|
Collagen | 2 | 2012 | 225 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 99 | 0.110 |
Why?
|
Mothers | 1 | 2014 | 88 | 0.110 |
Why?
|
Adolescent | 6 | 2018 | 3568 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 3 | 2018 | 49 | 0.110 |
Why?
|
Aminopeptidases | 1 | 2012 | 3 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 412 | 0.110 |
Why?
|
Thiazepines | 2 | 2002 | 3 | 0.110 |
Why?
|
Heart Failure | 1 | 2019 | 639 | 0.110 |
Why?
|
Endopeptidases | 1 | 2012 | 26 | 0.100 |
Why?
|
Biopterin | 1 | 2012 | 3 | 0.100 |
Why?
|
Nitrites | 1 | 2012 | 21 | 0.100 |
Why?
|
Ecotoxicology | 1 | 2012 | 1 | 0.100 |
Why?
|
Podocytes | 1 | 2012 | 20 | 0.100 |
Why?
|
Toxicity Tests | 1 | 2012 | 13 | 0.100 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 21 | 0.100 |
Why?
|
Nanostructures | 1 | 2012 | 19 | 0.100 |
Why?
|
Water-Electrolyte Balance | 1 | 2011 | 16 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2011 | 16 | 0.100 |
Why?
|
Fetal Weight | 1 | 2011 | 6 | 0.100 |
Why?
|
Antigens, CD | 1 | 2012 | 103 | 0.100 |
Why?
|
Membranes | 2 | 2008 | 10 | 0.100 |
Why?
|
Fetal Growth Retardation | 1 | 2011 | 34 | 0.100 |
Why?
|
Mediodorsal Thalamic Nucleus | 1 | 2011 | 5 | 0.100 |
Why?
|
Hydralazine | 1 | 2011 | 7 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 112 | 0.100 |
Why?
|
Captopril | 1 | 2011 | 8 | 0.100 |
Why?
|
Muscle Contraction | 1 | 2012 | 114 | 0.100 |
Why?
|
Vasoconstrictor Agents | 2 | 2009 | 61 | 0.100 |
Why?
|
Heart Atria | 1 | 2011 | 65 | 0.100 |
Why?
|
Aged | 4 | 2016 | 10314 | 0.090 |
Why?
|
Iodine Radioisotopes | 2 | 2011 | 16 | 0.090 |
Why?
|
Endothelin-1 | 3 | 2010 | 18 | 0.090 |
Why?
|
Radioligand Assay | 1 | 2010 | 20 | 0.090 |
Why?
|
Epistaxis | 1 | 2010 | 1 | 0.090 |
Why?
|
Moraxellaceae Infections | 1 | 2010 | 2 | 0.090 |
Why?
|
Moraxella | 1 | 2010 | 2 | 0.090 |
Why?
|
Macaca | 1 | 2010 | 27 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 91 | 0.090 |
Why?
|
Homeostasis | 2 | 2019 | 132 | 0.090 |
Why?
|
Pregnancy Complications | 1 | 2011 | 105 | 0.090 |
Why?
|
Catalase | 1 | 2010 | 15 | 0.090 |
Why?
|
Monkey Diseases | 1 | 2010 | 20 | 0.090 |
Why?
|
Case-Control Studies | 2 | 2018 | 898 | 0.090 |
Why?
|
PPAR gamma | 1 | 2010 | 46 | 0.090 |
Why?
|
Isoenzymes | 2 | 2007 | 61 | 0.090 |
Why?
|
Women's Health | 1 | 2011 | 235 | 0.090 |
Why?
|
SARS Virus | 2 | 2009 | 7 | 0.090 |
Why?
|
Severe Acute Respiratory Syndrome | 2 | 2009 | 10 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2009 | 58 | 0.090 |
Why?
|
Cell Membrane | 2 | 2009 | 96 | 0.080 |
Why?
|
Maleimides | 1 | 2009 | 5 | 0.080 |
Why?
|
Crosses, Genetic | 2 | 2006 | 20 | 0.080 |
Why?
|
Respiratory System | 1 | 2009 | 11 | 0.080 |
Why?
|
Behavior, Animal | 1 | 2011 | 250 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2009 | 31 | 0.080 |
Why?
|
Autoradiography | 1 | 2009 | 45 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 263 | 0.080 |
Why?
|
Natriuresis | 1 | 2008 | 4 | 0.080 |
Why?
|
Disease Progression | 2 | 2019 | 594 | 0.080 |
Why?
|
Indoles | 1 | 2009 | 56 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 198 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 767 | 0.080 |
Why?
|
Protein Binding | 1 | 2009 | 201 | 0.080 |
Why?
|
Alcoholism | 1 | 2009 | 101 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2009 | 122 | 0.080 |
Why?
|
Uterus | 1 | 2009 | 103 | 0.080 |
Why?
|
Hypotension | 2 | 2011 | 47 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 85 | 0.080 |
Why?
|
Inflammation | 1 | 2012 | 530 | 0.080 |
Why?
|
Succinates | 1 | 2008 | 6 | 0.080 |
Why?
|
Kidney Tubules | 1 | 2008 | 26 | 0.080 |
Why?
|
Anxiety | 1 | 2009 | 191 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2008 | 22 | 0.080 |
Why?
|
North Carolina | 2 | 2018 | 1538 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 120 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2017 | 834 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2009 | 221 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 43 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2007 | 12 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2007 | 73 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 84 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2006 | 14 | 0.070 |
Why?
|
Insulin | 2 | 2011 | 367 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 37 | 0.070 |
Why?
|
Models, Genetic | 1 | 2006 | 94 | 0.070 |
Why?
|
Growth Hormone | 1 | 2006 | 15 | 0.070 |
Why?
|
Heterozygote | 1 | 2006 | 59 | 0.070 |
Why?
|
Gene Silencing | 1 | 2005 | 48 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2007 | 256 | 0.070 |
Why?
|
Hypertension, Renovascular | 1 | 2005 | 15 | 0.060 |
Why?
|
Viral Envelope Proteins | 1 | 2005 | 10 | 0.060 |
Why?
|
Serine Endopeptidases | 1 | 2005 | 20 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2008 | 604 | 0.060 |
Why?
|
Microinjections | 3 | 2011 | 35 | 0.060 |
Why?
|
Astrocytes | 1 | 2005 | 58 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 114 | 0.060 |
Why?
|
Adult | 4 | 2021 | 9380 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 91 | 0.060 |
Why?
|
Lung Diseases | 1 | 2005 | 46 | 0.060 |
Why?
|
Body Mass Index | 2 | 2018 | 923 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 101 | 0.060 |
Why?
|
Ischemia | 1 | 2005 | 98 | 0.060 |
Why?
|
Polyuria | 1 | 2004 | 3 | 0.060 |
Why?
|
Diuresis | 1 | 2004 | 6 | 0.060 |
Why?
|
Organ Specificity | 1 | 2004 | 81 | 0.060 |
Why?
|
Creatinine | 2 | 2018 | 195 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 1542 | 0.060 |
Why?
|
Myocardial Contraction | 3 | 2011 | 63 | 0.060 |
Why?
|
F2-Isoprostanes | 1 | 2003 | 20 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 1497 | 0.060 |
Why?
|
Free Radicals | 1 | 2003 | 9 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2003 | 56 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2003 | 107 | 0.050 |
Why?
|
Atrial Natriuretic Factor | 1 | 2002 | 10 | 0.050 |
Why?
|
Phenotype | 2 | 2017 | 632 | 0.050 |
Why?
|
Gene Expression | 2 | 2013 | 338 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 2002 | 45 | 0.050 |
Why?
|
Genotype | 2 | 2016 | 733 | 0.050 |
Why?
|
Bacteroides | 1 | 2021 | 8 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 8 | 0.050 |
Why?
|
Lactobacillus | 1 | 2021 | 14 | 0.050 |
Why?
|
Feces | 1 | 2021 | 38 | 0.050 |
Why?
|
Animals, Newborn | 2 | 2012 | 114 | 0.050 |
Why?
|
Leptin | 2 | 2011 | 71 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 1428 | 0.050 |
Why?
|
Primates | 1 | 2021 | 108 | 0.050 |
Why?
|
Antioxidants | 2 | 2012 | 115 | 0.050 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2011 | 11 | 0.050 |
Why?
|
Perfusion | 2 | 2011 | 73 | 0.040 |
Why?
|
Potassium | 2 | 2010 | 40 | 0.040 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2019 | 5 | 0.040 |
Why?
|
Drug Combinations | 1 | 2019 | 98 | 0.040 |
Why?
|
Vasoconstriction | 2 | 2009 | 43 | 0.040 |
Why?
|
Rats, Inbred F344 | 2 | 2011 | 133 | 0.040 |
Why?
|
Diet | 1 | 2021 | 391 | 0.040 |
Why?
|
Hyperglycemia | 2 | 2010 | 84 | 0.040 |
Why?
|
Middle Aged | 3 | 2016 | 11839 | 0.040 |
Why?
|
Blood Glucose | 2 | 2011 | 494 | 0.040 |
Why?
|
Chemokine CXCL5 | 1 | 2017 | 3 | 0.040 |
Why?
|
Drinking | 2 | 2009 | 10 | 0.040 |
Why?
|
Protein Stability | 1 | 2017 | 25 | 0.040 |
Why?
|
Fetal Organ Maturity | 1 | 2016 | 7 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2016 | 6 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2016 | 29 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2016 | 81 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2016 | 20 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2016 | 33 | 0.030 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2015 | 4 | 0.030 |
Why?
|
Swine | 1 | 2016 | 215 | 0.030 |
Why?
|
Protein Precursors | 1 | 2015 | 22 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 59 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 18 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2015 | 57 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 40 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 78 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 45 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2016 | 765 | 0.030 |
Why?
|
Mast Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2013 | 30 | 0.030 |
Why?
|
Obesity | 1 | 2021 | 1176 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 2283 | 0.030 |
Why?
|
Cyclic N-Oxides | 1 | 2012 | 8 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 2265 | 0.030 |
Why?
|
Spin Labels | 1 | 2012 | 24 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2012 | 17 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2012 | 86 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 14 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 18 | 0.030 |
Why?
|
Ion Channels | 1 | 2012 | 24 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 36 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 43 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 2012 | 30 | 0.030 |
Why?
|
Soil Microbiology | 1 | 2012 | 2 | 0.030 |
Why?
|
Comet Assay | 1 | 2012 | 3 | 0.030 |
Why?
|
Micronucleus Tests | 1 | 2012 | 4 | 0.030 |
Why?
|
Fishes | 1 | 2012 | 8 | 0.030 |
Why?
|
Injections | 1 | 2012 | 64 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2012 | 30 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2014 | 684 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2012 | 63 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2012 | 20 | 0.030 |
Why?
|
Biological Assay | 1 | 2012 | 19 | 0.030 |
Why?
|
Metals | 1 | 2012 | 18 | 0.030 |
Why?
|
Particle Size | 1 | 2012 | 46 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 43 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 1817 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2012 | 47 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2012 | 66 | 0.020 |
Why?
|
Postmenopause | 1 | 2014 | 430 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2011 | 5 | 0.020 |
Why?
|
Animals, Suckling | 1 | 2011 | 4 | 0.020 |
Why?
|
Sucking Behavior | 1 | 2011 | 4 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 19 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2011 | 17 | 0.020 |
Why?
|
Ultrasonography | 1 | 2014 | 379 | 0.020 |
Why?
|
Vasopressins | 1 | 2011 | 17 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2011 | 31 | 0.020 |
Why?
|
Reference Values | 1 | 2011 | 246 | 0.020 |
Why?
|
Anesthesia | 1 | 2011 | 64 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 19 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2011 | 57 | 0.020 |
Why?
|
Sequence Analysis | 1 | 2010 | 5 | 0.020 |
Why?
|
Nasopharynx | 1 | 2010 | 8 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2010 | 14 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 293 | 0.020 |
Why?
|
Acetophenones | 1 | 2010 | 2 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2010 | 4 | 0.020 |
Why?
|
Sexual Maturation | 1 | 2010 | 25 | 0.020 |
Why?
|
Species Specificity | 1 | 2010 | 90 | 0.020 |
Why?
|
Renal Blood Flow, Effective | 1 | 2010 | 1 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2010 | 6 | 0.020 |
Why?
|
Lithium | 1 | 2010 | 5 | 0.020 |
Why?
|
Protein Kinase C-epsilon | 1 | 2009 | 5 | 0.020 |
Why?
|
Serine Proteases | 1 | 2009 | 1 | 0.020 |
Why?
|
Base Sequence | 1 | 2010 | 252 | 0.020 |
Why?
|
Arterioles | 1 | 2009 | 13 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 6 | 0.020 |
Why?
|
Echocardiography | 1 | 2010 | 159 | 0.020 |
Why?
|
Receptors, GABA-B | 1 | 2009 | 13 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 359 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 52 | 0.020 |
Why?
|
Probability | 1 | 2009 | 159 | 0.020 |
Why?
|
Cytokines | 1 | 2011 | 256 | 0.020 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 7 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2009 | 21 | 0.020 |
Why?
|
Cell Polarity | 1 | 2009 | 16 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 36 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 14 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 2009 | 8 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2009 | 45 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 45 | 0.020 |
Why?
|
Urodynamics | 1 | 2009 | 37 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2009 | 75 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 99 | 0.020 |
Why?
|
Amygdala | 1 | 2009 | 61 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2010 | 135 | 0.020 |
Why?
|
Renal Plasma Flow, Effective | 1 | 2008 | 1 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2009 | 143 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2009 | 117 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 100 | 0.020 |
Why?
|
Eating | 1 | 2009 | 74 | 0.020 |
Why?
|
Models, Molecular | 1 | 2009 | 193 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 276 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 288 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2008 | 13 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 2665 | 0.020 |
Why?
|
Renal Circulation | 1 | 2007 | 13 | 0.020 |
Why?
|
Superoxides | 1 | 2007 | 19 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2007 | 19 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2007 | 16 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 23 | 0.020 |
Why?
|
Ethanol | 1 | 2009 | 189 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 67 | 0.020 |
Why?
|
Lateral Ventricles | 1 | 2005 | 2 | 0.020 |
Why?
|
Subfornical Organ | 1 | 2005 | 4 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2005 | 13 | 0.020 |
Why?
|
Computer Systems | 1 | 2005 | 12 | 0.020 |
Why?
|
Rats, Inbred BN | 1 | 2006 | 31 | 0.020 |
Why?
|
Valine | 1 | 2005 | 14 | 0.020 |
Why?
|
Cerebellum | 1 | 2005 | 26 | 0.020 |
Why?
|
Adenoviridae | 1 | 2005 | 66 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2005 | 120 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2011 | 3990 | 0.010 |
Why?
|
Ligation | 1 | 2003 | 56 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 7 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2002 | 4 | 0.010 |
Why?
|
X Chromosome | 1 | 2002 | 26 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2002 | 11 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2002 | 28 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2002 | 47 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 75 | 0.010 |
Why?
|
Gene Deletion | 1 | 2002 | 67 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2002 | 42 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2002 | 525 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2002 | 3306 | 0.010 |
Why?
|